SEC Form 4 · accession 0001437749-19-000255
BIOLARGO, INC. · BLGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Kent Charles Roberts II
Director
Period of report
Dec 31, 2018
Accepted (ET)
Jan 3, 2019 · 6:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880242
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $0.24 | Dec 31, 2018 | A | 125,000 | A | Dec 31, 2018 | Dec 31, 2028 | Common stock | 125,000 | 1,304,445 | D |
Explanation of responses
- F1This Option was issued to Reporting Person as payment for $15,000 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the three months ended December 31, 2018, pursuant to the Issuer's 2018 Equity Incentive Plan.